Cannell & Spears’s Universal Health Services UHS Stock Holding History

Cannell & Spears’s Portfolio UHS Stock Details UHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,000	Closed	-$218K	–	439
2025 Q4	$218K	Hold	1,000	–	–	﹤0.01%	388
2025 Q3	$204K	Buy	+1,000	New	+$180K	﹤0.01%	381
2024 Q4	–	Sell	-1,000	Closed	-$229K	–	423
2024 Q3	$229K	Buy	+1,000	New	+$215K	﹤0.01%	368

Other funds holding UHS

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cannell & Spears's UHS Position: Q1 2026 in Review

Cannell & Spears sold out of Universal Health Services (UHS) in Q1 2026, closing a stake of 1,000 shares — an estimated $218K sold.

Cannell & Spears first reported a position in UHS in Q3 2024 and held it in 3 quarters. The position peaked at $229K in Q3 2024. 654 funds tracked by Wall St. Rank hold UHS as of Q1 2026.

Cannell & Spears reported no remaining Universal Health Services position as of Q1 2026 after selling out during the quarter.
Cannell & Spears sold 1,000 Universal Health Services shares in Q1 2026, an estimated $218K.
Cannell & Spears first reported a position in Universal Health Services in Q3 2024 and held it in 3 quarters.
Cannell & Spears's Universal Health Services position peaked at $229K in Q3 2024.
654 funds tracked by Wall St. Rank held Universal Health Services as of Q1 2026.

Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.